Literature DB >> 4021682

Malignant transformation in non-irradiated recurrent respiratory papillomatosis.

D Solomon, R R Smith, H K Kashima, B G Leventhal.   

Abstract

The clinical, radiographic and post mortem findings occurring in a 6-year-old female with a four-year history of recurrent respiratory papillomatosis (RRP) are described. At autopsy, there were two separate foci of malignant transformation (malignant degeneration) in the bronchioloalveolar papillomata. This patient is the youngest in whom such changes have been described. Malignant transformation is a rare occurrence and is usually seen in older patients with longstanding papillomatosis, therapeutic irradiation, or a history of smoking. Pulmonary spread represents the majority of cases with "spontaneous" malignant transformation.

Entities:  

Mesh:

Year:  1985        PMID: 4021682     DOI: 10.1288/00005537-198508000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

2.  Prognostic value of clinical findings in histologically verified adult-onset laryngeal papillomas.

Authors:  L M Aaltonen; J Peltomaa; H Rihkanen
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 3.  Squamous-cell carcinoma arising in a non-irradiated child with recurrent respiratory papillomatosis.

Authors:  B Simma; R Burger; J Uehlinger; D Ghelfi; E Hof; P Dangel; J Briner; S Fanconi
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

4.  A Case of the Intrapulmonary Spread of Recurrent Respiratory Papillomatosis With Malignant Transformation.

Authors:  Yang Xiao; Jun Wang; Demin Han; Lijing Ma
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

5.  Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Authors:  Turid Omland; Kathrine A Lie; Harriet Akre; Lars Erik Sandlie; Peter Jebsen; Leiv Sandvik; Dag Andre Nymoen; Davit Bzhalava; Joakim Dillner; Kjell Brøndbo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.